These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 15510392)

  • 1. Anemia during treatment of hepatitis C in HIV-infected patients.
    Lo Re V; Kostman JR
    AIDS Read; 2004 Oct; 14(10):555-7, 562, 565-71. PubMed ID: 15510392
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial comment: erythropoietin for treatment-related anemia in persons with hepatitis C--questions remain.
    Yachimski P; Chung RT
    AIDS Read; 2004 Oct; 14(10):568-9. PubMed ID: 15510393
    [No Abstract]   [Full Text] [Related]  

  • 3. Anemia in the treatment of hepatitis C virus infection.
    Sulkowski MS
    Clin Infect Dis; 2003; 37 Suppl 4():S315-22. PubMed ID: 14582000
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis C: new treatment overview.
    Stoia J
    AIDS Treat News; 1998 Sep; (302):5-6. PubMed ID: 11365763
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cost of treating ribavirin-induced anemia in hepatitis C: the impact of using recombinant human erythropoietin.
    Devine EB; Cross JT; Kowdley KV; Sullivan SD
    Curr Med Res Opin; 2007 Jun; 23(6):1463-72. PubMed ID: 17559739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV and hepatitis C virus coinfection: bad bedfellows.
    Schooley RT
    Top HIV Med; 2005; 13(4):112-6. PubMed ID: 16304454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Update on hepatitis C treatment in HIV-coinfected patients.
    Camino N; Sheldon J; Soriano V
    Minerva Gastroenterol Dietol; 2004 Mar; 50(1):67-77. PubMed ID: 15719008
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anemia--a complication of antiviral treatment in chronic viral hepatitis C.
    Orāşan O; Cozma A; Rednic N; Sâmpelean D; Pârvu A; Petrov L
    Rom J Intern Med; 2009; 47(3):217-25. PubMed ID: 20446436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythropoiesis-stimulating agent use for anemia induced by interferon-ribavirin treatment in patients with hepatitis C virus infection is not associated with increased rates of cardiovascular disease, thrombosis, malignancy, or death.
    Costiniuk CT; Camacho F; Cooper CL
    Clin Infect Dis; 2008 Jul; 47(2):198-202. PubMed ID: 18532889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of hepatitis C virus/HIV coinfection.
    Chun S; Sherman KE
    Clin Liver Dis; 2005 Aug; 9(3):525-33, ix. PubMed ID: 16023981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV and hepatitis C coinfection.
    Matthews GV; Dore GJ
    J Gastroenterol Hepatol; 2008 Jul; 23(7 Pt 1):1000-8. PubMed ID: 18707597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HCV kinetics, quasispecies, and clearance in treated HCV-infected and HCV/HIV-1-coinfected patients with hemophilia.
    Shire NJ; Horn PS; Rouster SD; Stanford S; Eyster ME; Sherman KE;
    Hepatology; 2006 Nov; 44(5):1146-57. PubMed ID: 17058240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HCV/HIV-coinfection--is there a state of the art after APRICOT and RIBAVIC?
    Mauss S; Rockstroh JK
    J Antimicrob Chemother; 2005 Oct; 56(4):615-8. PubMed ID: 16115826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
    Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination treatment for hepatitis C can be hazardous in patients co-infected with HIV.
    Schvarcz R; Moberg L; Sönnerborg A
    Antivir Ther; 1998; 3(4):233-4. PubMed ID: 10682144
    [No Abstract]   [Full Text] [Related]  

  • 16. Hepatitis C Virus in the HIV-infected patient.
    Andersson K; Chung RT
    Clin Liver Dis; 2006 May; 10(2):303-20, viii. PubMed ID: 16971263
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial DNA depletion in HIV-infected patients is more pronounced with chronic hepatitis C and enhanced following treatment with pegylated interferon plus ribavirin.
    de Mendoza C; Sánchez-Conde M; Timmermans E; Buitelaar M; de Baar MP; Gonzalez-Lahoz J; Soriano V
    Antivir Ther; 2005; 10(4):557-61. PubMed ID: 16038482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus infection in dialysis patients.
    Sułowicz W; Radziszewski A; Chowaniec E
    Hemodial Int; 2007 Jul; 11(3):286-95. PubMed ID: 17576291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Monitoring depression in patients undergoing alpha-interferon and ribavirin therapy for hepatitis C.
    Wright IA
    Gastroenterol Nurs; 2000; 23(6):275-80. PubMed ID: 11854972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Side effects. Safety and effectiveness of interferon and ribavirin in HIV+ people co-infected with hepatitis C virus.
    TreatmentUpdate; 2001; 12(8):4-5. PubMed ID: 12132439
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.